We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Brainomix Stock

Invest in or calculate the value of your shares in Brainomix or other pre-IPO companies through EquityZen's platform.

Get Started
View More Companies

Brainomix Stock

Brainomix specializes in the creation of AI-powered imaging biomarkers that enable precision medicine for better treatment decisions

Invest NowSell Shares

About Brainomix Stock

Founded

2010

Industries

Software, Artificial Intelligence, Data and Analytics

Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providing real-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.

Brainomix Management

Leadership team at Brainomix

CEO & Co-Founder

Michalis Papadakis

Chief Medical and Innovation Officer

George Harston

Locked Features

Join now and verify your accreditation status to gain access to:

  • Brainomix Current Valuation
  • Brainomix Stock Price
  • Brainomix Management
  • Available deals in Brainomix and all other companies with relevant Deal Offering documents
  • EquityZen's proprietary data and insights, which may include
    • Brainomix Cap Table and Funding History by Share Class and Liquidity Preferences
    • Brainomix Revenue and Financials
    • Brainomix Highlights
    • Brainomix Business Model
    • Brainomix Risk Factors
  • Brainomix Research Report from SACRA Research
Join Now

Trading Brainomix Stock

How to invest in Brainomix stock?

Accredited investors can buy pre-IPO stock in companies like Brainomix through EquityZen funds. These investments are made available by existing Brainomix shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Brainomix stock?

Shareholders can sell their Brainomix stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."

More Like Brainomix